Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor.

作者: Cristina Puy , Erik I. Tucker , Anton Matafonov , Qiufang Cheng , Keith D. Zientek

DOI: 10.1182/BLOOD-2014-10-604587

关键词: Flow cytometryBiochemistryActivated factor XIBlotEndotheliumHemostasisCoagulation factor XITissue factor pathway inhibitorCell biologyFibrinChemistry

摘要: Activation of coagulation factor XI (FXI) may play a role in hemostasis. The primary substrate activated FXI (FXIa) is FIX, leading to FX activation (FXa) and thrombin generation. However, recent studies suggest the hemostatic not be restricted FIX. We explored whether could interact with inhibit activity tissue pathway inhibitor (TFPI). TFPI an essential reversible X also inhibits FVIIa-TF complex. found that FXIa neutralized both endothelium- platelet-derived by cleaving protein between Kunitz (K) 1 K2 domains (Lys86/Thr87) at active sites (Arg107/Gly108) K3 (Arg199/Ala200) domains. Addition plasma was able reverse ability prolong TF-initiated clotting times FXI- or FIX-deficient plasma, as well FXa-initiated FX-deficient plasma. Treatment cultured endothelial cells increased generation FXa promoted TF-dependent fibrin formation recalcified Together, these results attributed only FIX but promoting extrinsic through inactivation TFPI.

参考文章(34)
Joseph E. Aslan, Asako Itakura, Jacqueline M. Gertz, Owen J. T. McCarty, Platelet shape change and spreading. Methods of Molecular Biology. ,vol. 788, pp. 91- 100 ,(2012) , 10.1007/978-1-61779-307-3_7
M Berrettini, R.R. Schleef, M.J. Heeb, P Hopmeier, J.H. Griffin, Assembly and expression of an intrinsic factor IX activator complex on the surface of cultured human endothelial cells. Journal of Biological Chemistry. ,vol. 267, pp. 19833- 19839 ,(1992) , 10.1016/S0021-9258(19)88630-1
W F Novotny, T J Girard, J P Miletich, G J Broze, Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. Journal of Biological Chemistry. ,vol. 264, pp. 18832- 18837 ,(1989) , 10.1016/S0021-9258(18)51542-8
C. LUPU, O. HERLEA, H. TANG, R. H. LIJNEN, F. LUPU, Plasmin‐dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia Journal of Thrombosis and Haemostasis. ,vol. 11, pp. 142- 148 ,(2013) , 10.1111/JTH.12044
M. F. WHELIHAN, T. ORFEO, M. T. GISSEL, K. G. MANN, Coagulation procofactor activation by factor XIa Journal of Thrombosis and Haemostasis. ,vol. 8, pp. 1532- 1539 ,(2010) , 10.1111/J.1538-7836.2010.03899.X
Wenman Wu, Hongbo Li, Duraiswamy Navaneetham, Zachary W. Reichenbach, Ronald F. Tuma, Peter N. Walsh, The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis Blood. ,vol. 120, pp. 671- 677 ,(2012) , 10.1182/BLOOD-2012-03-419523
D. Gailani, G. J. Broze, Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagulation & Fibrinolysis. ,vol. 4, pp. 15- 20 ,(1993) , 10.1097/00001721-199304010-00003
Thomas J. Girard, Louise A. Warren, William F. Novotny, Karen M. Likert, Susan G. Brown, Joseph P. Miletich, George J. Broze, Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor Nature. ,vol. 338, pp. 518- 520 ,(1989) , 10.1038/338518A0
Brian Pedersen, Todd Holscher, Yuichiro Sato, Rafal Pawlinski, Nigel Mackman, A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice Blood. ,vol. 105, pp. 2777- 2782 ,(2005) , 10.1182/BLOOD-2004-09-3724